Earlier, Dr. Zafar Mirza, Special Assistant to the Prime Minister of Health had said, “We are starting with Sindh Province, where the need is most urgent.”
According to a report published by the World Health Organization (WHO) in 2017, around 63 percent of typhoid cases and 70 percent of typhoid deaths in Pakistan were among children younger than 15 years of age.
Typbar-TCV is a typhoid conjugate vaccine manufactured by Bharat Biotech International Limited. It contains purified Vi capsular polysaccharide of Salmonella enterica serovar Typhi Ty2 conjugated to a tetanus toxoid carrier protein.
The vaccine, that confers longer-term protection against typhoid, can be administered to children as young as 6 months.